|
|
||||
|
Egging on the flu vaccine
The Scientist 2004, 18(21):12
|
||||
|
|
||||
|
The October 5 announcement by the Chiron Corporation that it could not ship nearly half the US supply of influenza vaccine has trained a spotlight on the vaccine production process. The ensuing public frenzy was abetted by a frightening flu season last year, stronger CDC recommendations on infant immunization, the looming threat of avian flu, and a harder push from public health groups for vulnerable populations to get immunized.
|
|
|||||||||
|
|||||||||
|